Literature DB >> 21881322

Mid-term results for the Maze procedure in patients with non-mitral valvular atrial fibrillation.

Tai Iwamura1, Kan Kajimoto, Taira Yamamoto, Motoshige Yamasaki, Keiichi Tambara, Yuki Yoneda, Atsushi Amano.   

Abstract

BACKGROUND: The Maze procedure in patients without mitral valve disease remains controversial, because of the increased invasiveness and operation time required to create additional incisions in the atria. The aim of this study was to assess prognosis following the Maze procedure in patients without mitral valve disease. METHODS AND
RESULTS: One hundred and seven consecutive patients who underwent the Maze procedure between 2002 and 2008 was enrolled in this study. Patients were divided into two groups based on the presence or absence of mitral valve disease. Freedom from atrial fibrillation was compared by multivariate logistic regression analysis at discharge. The Kaplan-Meier method and Cox-proportional hazard analysis adjusted for other predictors were estimated to compare freedom from atrial fibrillation at follow-up. Follow-up was 98% complete and mean duration of follow-up was 457 days. Operation and aorta cross-clamp times were similar between groups. No differences were identified in freedom from atrial fibrillation at discharge (non-mitral valve surgery, 55% vs. mitral valve surgery, 66%) or follow-up (57% vs. 61%, respectively). In multivariate Cox proportional hazard modelling, the presence of mitral valve disease was not associated with a poor success rate of conversion.
CONCLUSIONS: Results of the Maze procedure for atrial fibrillation without mitral valve disease were acceptable. The Maze procedure could be a beneficial option for these patients to avoid adverse events of atrial fibrillation.

Entities:  

Mesh:

Year:  2011        PMID: 21881322     DOI: 10.5761/atcs.oa.10.01606

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  1 in total

1.  Adjunctive surgical atrial fibrillation ablation during cardiac surgery: real life experiences.

Authors:  T S Tischer; R Schneider; J Lauschke; C Nesselmann; G Steinhoff; Dietmar Bänsch
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.